LifeVantage joins with Cornerstone R&D
This article was originally published in The Tan Sheet
San Diego, Calif.-based nutraceutical firm LifeVantage Corporation teams with Utah-based Cornerstone Research and Development firm to cut product manufacturing costs significantly, LifeVantage says in an Aug. 21 release. The merger will cut in half the costs for manufacturing LifeVantage's anti-oxidant therapy Protandim, the firm's President and CEO David Brown says. LifeVantage also points out Cornerstone's good manufacturing practice certification will boost business opportunities for the firm
You may also be interested in...
Join us for an audio roundup of major events in the global biopharma industry over the past week, as reported by Scrip.
Keeping Track: New Nucala Indication; BMS’ Ide-Cel Clears Filing Hurdle; First Applications From Telix And ADC Therapeutics
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
The National Advertising Division has notified the US Federal Trade Commission of claims seen at Bloomingdales.com for one of Mask, LLC’s CBD-infused sheet masks, including the product’s name, which implies unsupported acne treatment benefits, according to the NAD.